16:32 EST GRI Bio (GRI) files to sell 1.58M shares of common stock for holders Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try
16:32 EST GRI Bio (GRI) files to sell 1.58M shares of common stock for holders Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try
GRI Bio (GRI) announced that on October 22, 2024 it closed its previously announced transaction involving the exercise of certain existing warrants to purchase an aggregate of 762,236 shares of
GRI Bio announced the presentation of preclinical data demonstrating its lead program GRI-0621 reduces important inflammatory and fibrotic drivers in Idiopathic Pulmonary Fibrosis. The poster titled, “Involvement of Type 1
GRI Bio has received a “Decision to Grant” notice from the Japan Patent Office for the patent application No. 2023-000750 titled, “Prevention and Treatment of Inflammatory Conditions.” The granted patent
GRI Bio announced the authorization of its Clinical Trial Application, CTA, by the Australian Medicines and Healthcare products Regulatory Agency, MHRA, and the Human Research Ethics Committee, HREC, to initiate